Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease.

[1]  C. Masters,et al.  Transmissible spongiform encephalopathies , 2004, The Lancet.

[2]  A. Aguzzi,et al.  Creutzfeldt–Jakob disease and inclusion body myositis: Abundant disease‐associated prion protein in muscle , 2004, Annals of neurology.

[3]  M. Capucchio,et al.  Critical Observations on BSE Control in Italy , 2003, Veterinary Research Communications.

[4]  C. Bonacina.  The BSE Emergency in Lombardy , 2003, Veterinary Research Communications.

[5]  G. Wells.  Pathogenesis of BSE , 2003, Veterinary Research Communications.

[6]  R. Bradley.  BSE Risks for Humans Consuming Beef and Beef Products: How Any Risks Are Managed , 2003, Veterinary Research Communications.

[7]  F. Maraschi,et al.  BSE: Active and Passive Control System. Data Comparison in the District of Lodi , 2003, Veterinary Research Communications.

[8]  V. Moretti,et al.  The 'BSE Strategic Project' of the National Council of Research: Results of Four Years of Research , 2003, Veterinary Research Communications.

[9]  J. Ironside,et al.  Variant Creutzfeldt-Jakob disease. , 2004, Folia neuropathologica.

[10]  A. Nardone.  Impact of BSE on Livestock Production System , 2003, Veterinary Research Communications.

[11]  C. V. van Duijn,et al.  REVIEW: Variant Creutzfeldt-Jakob disease , 2002, European Journal of Epidemiology.

[12]  W. Nailon,et al.  Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. , 2004, The American journal of pathology.

[13]  Quantifying BSE control by calculating the basic reproduction ratio R0 for the infection among cattle , 2004, Journal of mathematical biology.

[14]  Wu-chang Yang,et al.  Creutzfeldt-Jakob-like EEG in a patient with end-stage renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  R. Dalton,et al.  Beef blockade greets first mad cow in United States , 2004, Nature.

[16]  B. Kuehn.  OIE: too few countries follow international BSE guidelines. , 2003, Journal of the American Veterinary Medical Association.

[17]  R. Sibley.  Continuing anxiety about BSE. , 2003, The Veterinary record.

[18]  M. Ferguson-Smith.  Continuing anxiety about BSE. , 2003, The Veterinary record.

[19]  E. Bozzetta,et al.  Bovine spongiform encephalopathy in Italian herds , 2003, Veterinary Record.

[20]  J. Giles.  Rapid drug trial offers hope to CJD patients , 2003, Nature.

[21]  M. Coulthart,et al.  Prion protein gene sequence of Canada's first non-imported case of bovine spongiform encephalopathy (BSE) , 2003 .

[22]  A. McLean,et al.  Epidemiological implications of the susceptibility to BSE of putatively resistant sheep. , 2003, The Journal of general virology.

[23]  L. McShane,et al.  Similar levels of infectivity in the blood of mice infected with human‐derived vCJD and GSS strains of transmissible spongiform encephalopathy , 2003, Transfusion.

[24]  K. Petry,et al.  Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt–Jakob disease , 2003, Neuropathology and applied neurobiology.

[25]  R. Knight.  Variant CJD: the present position and future possibilities. , 2003, International journal of pediatric otorhinolaryngology.

[26]  N. Kapur,et al.  The neuropsychological profile associated with variant Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[27]  Richard T. Johnson,et al.  Diagnosis and prevention of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. , 2003, Annual review of medicine.

[28]  vCJD risk in the Republic of Ireland , 2003, BMC infectious diseases.

[29]  G. Coles,et al.  Changing behaviour in the common horse tapeworm. , 2003, The Veterinary record.

[30]  T. Baron,et al.  Neuropathological characterisation of French bovine spongiform encephalopathy cases , 2003, Histochemistry and Cell Biology.

[31]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[32]  S. Blamey,et al.  Potential transmission of Creutzfeldt-Jakob disease after low-risk surgery. , 2003, The Journal of hospital infection.

[33]  P. Lasch,et al.  Antemortem identification of bovine spongiform encephalopathy from serum using infrared spectroscopy. , 2003, Analytical chemistry.

[34]  J. Wilesmith,et al.  Modelling studies on bovine spongiform encephalopathy occurrence to assist in the review of the over 30 months rule in Great Britain , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[35]  M. Willerroider.  Routine tests reveal unknown strains of BSE prions , 2003, Nature.

[36]  B. Kuehn.  Canada wraps up BSE investigation. , 2003, Journal of the American Veterinary Medical Association.

[37]  G. Cossu,et al.  Creutzfeldt-Jakob disease associated with high titer of antithyroid autoantibodies: case report and literature review , 2003, Neurological Sciences.

[38]  S. Bird,et al.  Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. , 2003, International journal of epidemiology.

[39]  A. Ghani.  Commentary: Predicting the unpredictable: the future incidence of variant Creutzfeldt-Jakob disease. , 2003, International journal of epidemiology.

[40]  J. Hoey.  Wild game feasts and fatal degenerative neurologic illness. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[41]  A. Leventhal,et al.  Bovine spongiform encephalopathy in Israel: implications for human health. , 2003, The Israel Medical Association journal : IMAJ.

[42]  C. Furman,et al.  Diagnostic Challenges in Creutzfeldt-Jakob Disease: Case Report , 2003, Southern medical journal.

[43]  J. Ironside,et al.  Variant Creutzfeldt–Jakob disease and its transmission by blood , 2003, Journal of thrombosis and haemostasis : JTH.

[44]  J. Burthem,et al.  The pathophysiology of variant creutzfeldt–jacob disease: the hypotheses behind concerns for blood components and products , 2003, British journal of haematology.

[45]  J. Ironside.  The spectrum of safety: variant Creutzfeldt-Jakob disease in the United Kingdom. , 2003, Seminars in hematology.

[46]  N. Hunter.  Scrapie and experimental BSE in sheep. , 2003, British medical bulletin.

[47]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[48]  M. Bruce.  TSE strain variation. , 2003, British medical bulletin.

[49]  Peter G. Smith,et al.  Bovine spongiform encephalopathy (BSE) and its epidemiology. , 2003, British medical bulletin.

[50]  M. Turner.  vCJD screening and its implications for transfusion--strategies for the future? , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[51]  B. Caughey,et al.  Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains. , 2003, British medical bulletin.

[52]  K. Schotten,et al.  Perceived Risk of Bovine Spongiform Encephalopathy and Dietary Behavior , 2003, Journal of health psychology.

[53]  R. Henry,et al.  Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[54]  S. Collins,et al.  Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease. , 2003, The Lancet. Infectious diseases.

[55]  P. Brown.  Variant CJD transmission through blood: risks to predictors and “predictees” , 2003, Transfusion.

[56]  C. Farrington,et al.  Deaths from variant Creutzfeldt-Jakob disease in the UK , 2003, The Lancet.

[57]  P. Brown,et al.  Transmissible spongiform encephalopathy update and implications for blood safety. , 2003, Clinics in laboratory medicine.

[58]  P. Zampieri,et al.  Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[59]  D. Booth,et al.  MHC typing in variant Creutzfeldt-Jakob disease , 2003, The Lancet.

[60]  J. Grassi.  Pre-clinical diagnosis of transmissible spongiform encephalopathies using rapid tests. , 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[61]  D. Taylor,et al.  Inactivation of TSE agents: safety of blood and blood-derived products. , 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[62]  M. Hampshire.  Home and away. , 2003, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[63]  L. Schonberger,et al.  Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States , 2003, Neurology.

[64]  D. Irani.  The classic and variant forms of Creutzfeldt-Jakob disease. , 2003, Seminars in clinical neuropsychiatry.

[65]  Peter G. Smith.  The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects. , 2003, Bulletin of the World Health Organization.

[66]  R. Will,et al.  Variant Creutzfeldt-Jakob Disease , 2005, Transfusion Medicine and Hemotherapy.

[67]  C. Masters,et al.  Apparently sporadic CJD and covert health-care transmissions , 2002, The Lancet Neurology.

[68]  A. McLean,et al.  BSE - a wolf in sheep's clothing? , 2002, Trends in microbiology.

[69]  L. Schonberger,et al.  Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. , 2002, Clinics in laboratory medicine.

[70]  P. Horby,et al.  Variant Creutzfeldt‐Jakob disease: An unfolding epidemic of misfolded proteins , 2002, Journal of paediatrics and child health.

[71]  J. Kaldor,et al.  Creutzfeldt–Jakob disease in Australia 1970–1999 , 2002, Neurology.

[72]  K. Taber,et al.  The expanding role of imaging in prion disease. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[73]  M. Bounias,et al.  Transmissible spongiform encephalopathies: a family of etiologically complex diseases--a review. , 2002, The Science of the total environment.

[74]  A. Ghani,et al.  Accumulation of prion protein in tonsil and appendix: review of tissue samples , 2002, BMJ : British Medical Journal.

[75]  D. Dormont,et al.  Prions, BSE and food. , 2002, International journal of food microbiology.

[76]  K. Niedzielska,et al.  Impairment of the peripheral nervous system in Creutzfeldt-Jakob disease. , 2002, Archives of neurology.

[77]  CV Prowse MA,et al.  Mad Cows and Englishmen: An Update on Blood and vCJD , 2002, Vox sanguinis.

[78]  D. Anstee.  Progress Towards a Blood Test for vCJD? , 2002, Vox sanguinis.

[79]  W. Rutala,et al.  Managing the risk of nosocomial transmission of prion diseases , 2002, Current Opinion in Infectious Diseases.

[80]  A. Aguzzi,et al.  Incidence of Creutzfeldt-Jakob disease in Switzerland , 2002, The Lancet.

[81]  C. Whitworth.  Variant Creutzfeldt-Jakob Disease—A Problem for General Dental Practitioners? , 2002, Primary dental care : journal of the Faculty of General Dental Practitioners.

[82]  R. Will,et al.  First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features , 2002, BMJ : British Medical Journal.

[83]  D. Taylor.  Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[84]  J. Ironside,et al.  Creutzfeldt-Jakob disease: implications for gastroenterology , 2002, Gut.

[85]  J. Carruthers,et al.  Mad cows, prions, and wrinkles. , 2002, Archives of dermatology.

[86]  A. Farrugia.  Risk of variant Creuzfeldt–Jakob disease from factor concentrates: current perspectives , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[87]  C. Henry,et al.  Clinical features of variant Creutzfeldt‐Jakob disease , 2002, Reviews in medical virology.

[88]  Benjamin H. Flores,et al.  Psychological versus biological clinical interpretation: a patient with prion disease. , 2002, The American journal of psychiatry.

[89]  P. Penar,et al.  Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. , 2002, AJNR. American journal of neuroradiology.

[90]  A. Ghani.  The epidemiology of variant Creutzfeldt-Jakob disease in Europe. , 2002, Microbes and infection.

[91]  D. Ropeik,et al.  Mad cow disease risk in the United States , 2002, Postgraduate medicine.

[92]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[93]  N. J. Dalsgaard.  Prion diseases. An overview , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[94]  I. Zerr,et al.  Clinical diagnosis and differential diagnosis of CJD and vCJD , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[95]  J. Ironside,et al.  Pathological diagnosis of variant Creutzfeldt‐Jakob disease , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[96]  A. Green.  Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. , 2001, Biochemical Society transactions.

[97]  Peter B Kingsley,et al.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. , 2002, Archives of neurology.

[98]  P. Griffiths,et al.  Preparing to treat prions , 2002, Reviews in medical virology.